CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PANCAID is developing a blood test for the early detection of pancreatic cancer. It aims to create a highly accurate multi-biomarker panel by analyzing blood samples from patients and at-risk individuals to improve diagnosis and reduce false positives.
Pancreatic cancer (PDAC) is usually detected at late stages and most patients die within one year after diagnosis.
In PANCAID we will therefore develop a blood test for early detection of PDAC.
Despite tremendous technological advances in Liquid Biopsy Diagnostics (LBx), this goal is very ambitious because small tumors release only minute amounts of cells or cellular products (e.g., DNA, RNA, protein, metabolites) into the circulation.
Thus, tests with a high sensitivity are required but increas…
UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, Stockholm
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III
Spain, Madrid
Type: Research institute
Activity type: Research Organisations
SME: No
Austria, Graz
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Sweden, Umea
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
